ACTICOAT Surgical

Silver-coated Antimicrobial Barrier Dressing

Overview

Description

ACTICOAT Surgical is an absorbent post-operative dressing consisting of the following:

  • A Nanocrystalline silver-coated polyurethane layer
  • A white polyurethane foam pad
  • An adhesive coated waterproof polyurethane film layer

ACTICOAT Surgical provides an effective barrier to bacterial penetration. In the presence of exudate the dressing will help maintain a moist wound environment. ACTICOAT Surgical may be left in place over a wound for up to 7 days.


Indications

ACTICOAT Surgical Dressing is indicated for use in light to moderately exuding partial and full thickness wounds including decubitus ulcers, diabetic ulcers, surgical wounds, 1st and 2nd degree burns, and donor sites. ACTICOAT Surgical dressing may be used over debrided and partial thickness wounds.


Contraindications

  • Do not use on patients with a known sensitivity to silver
  • Do not use on patients during MRI (Magnetic Resonance Imaging) examination
  • Prior to commencing radiation therapy remove ACTICOAT Surgical. A new dressing can be applied following treatment


Precautions

  • For external use only
  • ACTICOAT Surgical is not compatible with oil-base products such as petrolatum
  • ACTICOAT Surgical may not be compatible with topical antimicrobials
  • Do not use ACTICOAT Surgical with saline
  • ACTICOAT Surgical is not compatible with oxidizing agents (eg. EUSOL) as these can break down the absorbent polyurethane component of the dressing
  • Avoid contact with electrodes or conductive gels during electronic measurements eg. EEG and ECG
  • ACTICOAT Surgical Dressings are not intended to provide treatment for infected wounds
  • ACTICOAT Surgical Dressings may be used on infected wounds which are being managed in accordance with institutional clinical protocols for infection abatement as an adjunct to the standard treatment regimen to provide a barrier to bacterial infection
  • As with all inappropriate use or too frequent dressing changes, particularly on patients with fragile skin, can result in skin stripping. If reddening or sensitization occur, discontinue use
  • ACTICOAT Surgical should only be used in premature infants (<3weeks gestation) when clinical benefit outweighs any potential patient risks>


Ordering Codes / Reimbursement Information

Product # Size Pcs/Pkg Pkg/Case HCPCS
66021770 4" x 4 3/4" 5 10 A6212
66021771 4' x 8" 5 5 A6212
66021772 4' x 10" 5 5 A6212
66800057 4' x 13 3/4" 5 5 A6213

Instructions for use

Prepare

Where required, wound cleansing should be performed according to local clinical protocol using sterile water only. Choose a dressing where the pad is larger than the wound. Remove the ACTICOAT Surgical Dressing from the pack using an aseptic technique. The dressing should not be moistened prior to use as it is indicated for use on wounds where there is some exudate present.


Step 1

ActicoatPostOp_Step1

Remove the first release paper. Place the silver layer in intimate contact with the wound bed. ensuring the entire surface is covered.


Step 2

ActicoatPostOP_Step2

Remove the second release paper and smooth the dressing down trying to avoid ridging of the film.


Step 3

ActicoatPostOP_Step3

Remove the top printed carrier marked "2". To remove the dressing, lift one corner and slowly stretch the film in a motion that is parallel to the skin.

Notes

  • The dressing should be changed at least every 7 days, but will require earlier changing if a strike through of exudate occurs
  • The dressing may adhere if used on lightly exuding wounds. If the dressing is not easily removed moisten or soak to assist removal and avoid disruption of the wound
  • ACTICOAT Surgical may cause transient discoloration of the surrounding skin